 <h1>Diazepam Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of diazepam include:</b> drowsiness and hypotonia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to diazepam: oral solution, oral tablet</i></p><p>Other dosage forms:</p><ul><li>injection solution</li><li>rectal gel/jelly</li></ul><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, or death. Reserve use for patients for whom alternative therapies are inadequate and limit use to lowest possible dose and shortest possible duration. Monitor for signs or symptoms of respiratory depression and sedation.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, diazepam may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking diazepam:</p><p>
<i>More common</i>
</p><ul>
<li>Shakiness and unsteady walk</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>agitation</li>
<li>black, tarry stools</li>
<li>blistering, flaking, or peeling of the skin</li>
<li>blurred vision</li>
<li>changes in patterns and rhythms of speech</li>
<li>chills</li>
<li>confusion</li>
<li>cough</li>
<li>dark urine</li>
<li>decrease in the frequency of urination</li>
<li>decrease in urine volume</li>
<li>difficulty in passing urine (dribbling)</li>
<li>discouragement</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>false beliefs that cannot be changed by facts</li>
<li>fast heartbeat</li>
<li>fast or irregular breathing</li>
<li>feeling sad or empty</li>
<li>feeling that others are watching you or controlling your behavior</li>
<li>feeling that others can hear your thoughts</li>
<li>feeling, seeing, or hearing things that are not there</li>
<li>fever</li>
<li>headache</li>
<li>hyperexcitability</li>
<li>increased muscle spasms or tone</li>
<li>irritability</li>
<li>itching or rash</li>
<li>lack of memory of what takes place after a certain event</li>
<li>loss of appetite</li>
<li>loss of bladder control</li>
<li>loss of interest or pleasure</li>
<li>lower back or side pain</li>
<li>nausea</li>
<li>nightmares</li>
<li>outbursts of anger</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>restlessness</li>
<li>seizures</li>
<li>slurred speech</li>
<li>sore throat</li>
<li>sweating</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>trouble speaking</li>
<li>ulcers, sores, or white spots in the mouth</li>
<li>unpleasant breath odor</li>
<li>unusual behavior</li>
<li>unusual bleeding or bruising</li>
<li>unusual feeling of excitement</li>
<li>unusual tiredness or weakness</li>
<li>vomiting of blood</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking diazepam:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Change in consciousness</li>
<li>difficult or troubled breathing</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>lack of coordination</li>
<li>loss of consciousness</li>
<li>loss of strength or energy</li>
<li>muscle pain or weakness</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>sleepiness</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness </li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of diazepam may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Constipation</li>
<li>decreased interest in sexual intercourse</li>
<li>diarrhea</li>
<li>difficulty with swallowing</li>
<li>double vision</li>
<li>dry mouth</li>
<li>feeling of constant movement of self or surroundings</li>
<li>inability to have or keep an erection</li>
<li>increase in sexual ability, desire, drive, or performance</li>
<li>increased interest in sexual intercourse</li>
<li>increased watering of the mouth</li>
<li>indigestion</li>
<li>loss of sexual ability, desire, drive, or performance</li>
<li>passing of gas</li>
<li>seeing double</li>
<li>sensation of spinning</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to diazepam: compounding powder, injectable solution, intravenous suspension, nasal spray, oral capsule extended release, oral concentrate, oral solution, oral tablet, rectal kit</i></p><h3>General</h3><p>ORAL: The most commonly reported side effects included ataxia, drowsiness, fatigue, and muscle weakness.</p>
<p></p>
<p>PARENTERAL: The most commonly reported side effects included fatigue, drowsiness, ataxia, injection-site venous thrombosis, and injection-site phlebitis.</p>
<p></p>
<p>RECTAL: The most commonly reported side effects included somnolence, headache, and diarrhea.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Drowsiness, headache, dizziness, ataxia, and reduced alertness occurred at the start of treatment, but usually disappeared with continued use.</p>
<p></p>
<p>Anterograde amnesia is a dose-related side effect that may occur at therapeutic doses.</p>
<p></p>
<p>Tremor, disrupted sensory perception, and epileptic attacks occurred in patients with withdrawal symptoms.</p>
<p></p>
<p>Drowsiness, sedation, unsteadiness, and ataxia are dose-related and may persist into the following day, even with single doses.</p>
<p></p>
<p>Prolonged use of treatment in elderly patients may result in dementia.<sup>[Ref]</sup></p><p>ORAL:</p>
<p><b>Common</b> (1% to 10%): Ataxia, disrupted sensory perception, drowsiness, epileptic attacks, impaired motor ability, tremor</p>
<p><b>Uncommon</b> (0.1% to 1%): Amnesia/anterograde amnesia, balance disorders, concentration difficulties, dizziness, dysarthria, headache, slurred speech, vertigo</p>
<p><b>Rare</b> (0.01% to 0.1%): Decreased alertness, memory loss, syncope, unconsciousness</p>
<p><b>Frequency not reported</b>: Abnormal taste, amnestic effects, hangover effect, hypersensitivity to physical/visual/auditory stimuli, oversedation, perceptual disturbances</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Common</b> (1% to 10%): Ataxia, disrupted sensory perception, dizziness, drowsiness, epileptic attacks, impaired motor ability, tremor</p>
<p><b>Uncommon</b> (0.1% to 1%): Amnesia/anterograde amnesia, balance disorders, concentration difficulties, headache, increased seizure incidence/severity, lightheadedness, minor electroencephalogram (EEG) changes, slurred speech, vertigo</p>
<p><b>Rare</b> (0.01% to 0.1%): Convulsions, decreased alertness, dysarthria, extrapyramidal effects, memory loss, syncope, unconsciousness</p>
<p><b>Frequency not reported</b>: Abnormal taste, amnestic effects, hangover effect, hypersensitivity to physical/visual/auditory stimuli, oversedation</p>
<p></p>
<p>RECTAL:</p>
<p><b>Very common</b> (10% or more): Somnolence (up to 23%)</p>
<p><b>Common</b> (1% to 10%): Ataxia, anterograde amnesia, convulsion, disrupted sensory perception, dizziness, drowsiness, dysarthria, epileptic attacks, hangover effect, headache, impaired motor ability, incoordination, reduced alertness, sedation, slurred speech, speech disorder, tremor, vertigo</p>
<p><b>Uncommon</b> (0.1% to 1%): Balance disorders, concentration difficulties</p>
<p><b>Rare</b> (0.01% to 0.1%): Dystonic effects, lightheadedness, memory loss, syncope, unconsciousness</p>
<p><b>Frequency not reported</b>: Grand mal convulsion, hyperkinesia, lethargy, minor changes in EEG patterns, nystagmus<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>ORAL:</p>
<p><b>Common</b> (1% to 10%): Aggression/aggressiveness, anxiety, confusion, delirium, irritability, panic, paranoid psychosis, withdrawal symptoms</p>
<p><b>Uncommon</b> (0.1% to 1%): Depression, changed/increased/reduced libido</p>
<p><b>Rare</b> (0.01% to 0.1%): Agitation, delusion, emotional poverty, excitation, hallucinations, inappropriate behavior, insomnia, nightmares, other adverse behavioral effects, psychiatric reactions, psychoses, rages, restlessness</p>
<p><b>Frequency not reported</b>: Acute hyperexcittion/acute hyperexcited states, broken sleep with vivid dreams, confusional psychosis, delirium tremens, increased REM sleep, numbed emotions, physical dependence, sleep disturbances, stimulation, unmasked depression</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Common</b> (1% to 10%): Aggression/aggressiveness, anxiety, confusion, delirium, dependence, irritability, panic, paranoid psychosis, withdrawal symptoms</p>
<p><b>Uncommon</b> (0.1% to 1%): Acute hyperexcittion/acute hyperexcited states, auditory/visual hallucinations, numbed emotion, sleep disturbances, stimulation, suicidal ideation</p>
<p><b>Rare</b> (0.01% to 0.1%): Agitation, delusion, depression/mental depression, emotional poverty, excitation, hallucinations, inappropriate behavior, increased/changed/reduced libido, insomnia, nightmares, other adverse behavioral effects, psychiatric reactions, psychoses, rages, restlessness</p>
<p><b>Frequency not reported</b>: Broken sleep with vivid dreams, confusional psychoses, delirium tremens, disinhibition, dysphoria, euphoria, habituation, hypoactivity, increased REM sleep, inhibition of female orgasm, unmasked depression</p>
<p></p>
<p>RECTAL:</p>
<p><b>Common</b> (1% to 10%): Aggression/aggressiveness, agitation, anxiety, confusion, delirium, emotional lability, euphoria, irritability, nervousness, numbed emotions, panic, paranoid psychosis, thinking abnormal, uneasiness, unmasked depression, withdrawal symptoms</p>
<p><b>Rare</b> (0.01% to 0.1%): Delusion, emotional poverty, excitation, hallucination, inappropriate behavior, increased/reduced libido, insomnia, libido fluctuations, nightmares, other adverse behavioral effects, psychiatric reactions, psychoses, rage, restlessness</p>
<p><b>Frequency not reported</b>: Abuse, acute hyperexcited states, changes in libido, depression, drug dependence, dysphoria, instability, sleep disturbances, stimulation, uncovering of depression with suicidal tendencies<sup>[Ref]</sup></p><p>Confusion and numbed emotions occurred at the start of treatment, but usually disappeared with continued use.  Confusion has occurred in elderly patients who received high doses.</p>
<p></p>
<p>Inappropriate behavior may occur with anterograde amnesia.</p>
<p></p>
<p>Psychic and physical dependence occurred with chronic use at therapeutic doses; withdrawal symptoms may occur in patients with dependence when treatment is discontinued.</p>
<p></p>
<p>Anxiety, panic, irritability, aggressiveness/aggression, paranoid psychosis, and delirium occurred in patients with withdrawal symptoms.</p>
<p></p>
<p>Restlessness, agitation, irritability, aggressiveness/aggression, rage, delusions, nightmares, psychoses, hallucinations, and inappropriate behavior occurred in patients with paradoxical reactions, especially in elderly and pediatric patients.</p>
<p></p>
<p>Increased REM sleep and broken sleep with vivid dreams may persist for weeks after treatment is discontinued.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Increased bronchial secretions were reported, especially in pediatric patients.</p>
<p></p>
<p>Respiratory depression and apnea occurred, especially with high doses.</p>
<p></p>
<p>Coughing, respiratory depression, dyspnea, hyperventilation, laryngospasm, and throat/chest pain have been reported in patients undergoing peroral endoscopic procedures.<sup>[Ref]</sup></p><p>ORAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Respiratory depression</p>
<p><b>Rare</b> (0.01% to 0.1%): Increased bronchial secretion, respiratory arrest</p>
<p><b>Frequency not reported</b>: Apnea</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Coughing, dyspnea, hyperventilation, laryngospasm, respiratory depression, throat pain</p>
<p><b>Rare</b> (0.01% to 0.1%): Increased bronchial secretion, respiratory arrest</p>
<p><b>Frequency not reported</b>: Apnea, hiccups</p>
<p></p>
<p>RECTAL:</p>
<p><b>Common</b> (1% to 10%): Asthma, hiccup, rhinitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Respiratory depression</p>
<p><b>Rare</b> (0.01% to 0.1%): Apnea, increased bronchial secretion, laryngeal spasm, respiratory arrest</p>
<p><b>Frequency not reported</b>: Cough increased, hypoventilation<sup>[Ref]</sup></p><h3>Other</h3><p>ORAL:</p>
<p><b>Common</b> (1% to 10%): Fatigue, general malaise</p>
<p><b>Rare</b> (0.01% to 0.1%): Paradoxical reactions</p>
<p><b>Frequency not reported</b>: Accidents, falls, rebound effect, tinnitus</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Common</b> (1% to 10%): Fatigue, general malaise</p>
<p><b>Uncommon</b> (0.1% to 1%): Body pain, hyperpyrexia, hypothermia</p>
<p><b>Rare</b> (0.01% to 0.1%): Paradoxical reactions</p>
<p><b>Frequency not reported</b>: Pain</p>
<p></p>
<p>RECTAL:</p>
<p><b>Common</b> (1% to 10%): Falls, fatigue, general malaise, pain, paradoxical reactions</p>
<p><b>Frequency not reported</b>: Asthenia, lack of effect, rebound effect<sup>[Ref]</sup></p><p>Fatigue occurred at the start of treatment, but usually disappeared with continued use.</p>
<p></p>
<p>Elderly patients have an increased risk of falling.</p>
<p></p>
<p>Patients with physical/psychic dependence may experience rebound effects during discontinuation.</p>
<p></p>
<p>General malaise occurred in patients with withdrawal symptoms.</p>
<p></p>
<p>Pain occurred with injection formulations.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Palpitations occurred in patients with withdrawal symptoms.</p>
<p></p>
<p>Thrombophlebitis and venous thrombosis have occurred with injection formulations.</p>
<p></p>
<p>Ischemia occurred with inadvertent intra-arterial administration.<sup>[Ref]</sup></p><p>ORAL:</p>
<p><b>Common</b> (1% to 10%): Hypotension, palpitations</p>
<p><b>Rare</b> (0.01% to 0.1%): Bradycardia, heart failure (including cardiac arrest)</p>
<p><b>Frequency not reported</b>: Cardiovascular depression, chest pain, mild systolic hypertension, orthostatic hypotension, tachycardia</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Common</b> (1% to 10%): Palpitations</p>
<p><b>Uncommon</b> (0.1% to 1%): Bradycardia, cardiac arrest, chest pain, hypotension, other arrhythmias, tachycardia, ventricular premature contractions</p>
<p><b>Frequency not reported</b>: Mild systolic hypertension, orthostatic hypotension</p>
<p></p>
<p>RECTAL:</p>
<p><b>Common</b> (1% to 10%): Hypotension, palpitations, vasodilation</p>
<p><b>Rare</b> (0.01% to 0.1%): Bradycardia, chest pain, heart failure (including cardiac arrest)</p>
<p><b>Frequency not reported</b>: Cardiovascular collapse<sup>[Ref]</sup></p><h3>Local</h3><p>PARENTERAL:</p>
<p><b>Common</b> (1% to 10%): Local irritation, pain, phlebitis, swelling, venous thrombosis</p>
<p><b>Uncommon</b> (0.1% to 1%): Erythema, local pain, tenderness, vascular changes</p>
<p><b>Frequency not reported</b>: Ischemia, tissue necrosis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Muscle weakness occurred at the start of treatment, but usually disappeared with continued use.</p>
<p></p>
<p>Elderly patients and/or those taking sedatives/alcohol concomitantly have an increased risk of fractures associated with falls.</p>
<p></p>
<p>Muscle spasms occurred in patients with withdrawal symptoms.</p>
<p></p>
<p>Tissue necrosis occurred with inadvertent intra-arterial administration.<sup>[Ref]</sup></p><p>ORAL:</p>
<p><b>Common</b> (1% to 10%): Muscle spasms, muscle weakness</p>
<p><b>Uncommon</b> (0.1% to 1%): Myasthenia</p>
<p><b>Frequency not reported</b>: Muscle twitching</p>
<p><b>Postmarketing reports</b>: Fractures</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Common</b> (1% to 10%): Muscle spasms/increased muscle spasticity, muscle weakness</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased phosphokinase activity, joint pain, muscle cramps, myasthenia</p>
<p><b>Frequency not reported</b>: Muscle aches, muscle twitching</p>
<p><b>Postmarketing reports</b>: Fractures</p>
<p></p>
<p>RECTAL:</p>
<p><b>Common</b> (1% to 10%): Muscle spasms, muscle weakness</p>
<p><b>Uncommon</b> (0.1% to 1%): Myasthenia</p>
<p><b>Frequency not reported</b>: Increased muscle spasticity, muscle cramps<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Increased salivation has been reported, especially in pediatric patients.</p>
<p></p>
<p>Gastrointestinal disorders occurred in patients with withdrawal symptoms.<sup>[Ref]</sup></p><p>ORAL:</p>
<p><b>Common</b> (1% to 10%): Gastrointestinal disorders</p>
<p><b>Uncommon</b> (0.1% to 1%): Constipation, diarrhea, dry mouth, hypersalivation, increased salivary secretion, nausea, vomiting</p>
<p><b>Frequency not reported</b>: Abdominal cramps</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Common</b> (1% to 10%): Gastrointestinal disorders</p>
<p><b>Uncommon</b> (0.1% to 1%): Constipation, decreased gag reflex, diarrhea, hypersalivation, increased salivary secretion, nausea, vomiting</p>
<p><b>Rare</b> (0.01% to 0.1%): Dry mouth</p>
<p><b>Frequency not reported</b>: Abdominal cramps, changes in salivation</p>
<p></p>
<p>RECTAL:</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, gastrointestinal disorders</p>
<p><b>Uncommon</b> (0.1% to 1%): Changes in salivation, constipation, increased salivary secretion, nausea, vomiting</p>
<p><b>Rare</b> (0.01% to 0.1%): Dry mouth, epigastric pain, obstipation</p>
<p><b>Frequency not reported</b>: Abdominal cramps<sup>[Ref]</sup></p><h3>Metabolic</h3><p>ORAL:</p>
<p><b>Common</b> (1% to 10%): Loss of appetite</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased appetite</p>
<p><b>Rare</b> (0.01% to 0.1%): Alkaline phosphatase elevations</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Common</b> (1% to 10%): Loss of appetite</p>
<p><b>Rare</b> (0.01% to 0.1%): Alkaline phosphatase elevations, increased appetite</p>
<p></p>
<p>RECTAL:</p>
<p><b>Common</b> (1% to 10%): Loss of appetite</p>
<p><b>Rare</b> (0.01% to 0.1%): Alkaline phosphatase elevations, increased appetite</p>
<p><b>Frequency not reported</b>: Anorexia<sup>[Ref]</sup></p><p>Appetite loss occurred in patients with withdrawal symptoms.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>ORAL:</p>
<p><b>Common</b> (1% to 10%): Sweating</p>
<p><b>Uncommon</b> (0.1% to 1%): Allergic skin reactions, erythema, itching, rash/skin rash</p>
<p><b>Frequency not reported</b>: Perspiration</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Allergic skin reactions, erythema, itching, photosensitivity, pruritus, rash/skin rash, urticaria</p>
<p><b>Frequency not reported</b>: Perspiration, Steven-Johnson syndrome, sweating</p>
<p></p>
<p>RECTAL:</p>
<p><b>Common</b> (1% to 10%): Rash, sweating</p>
<p><b>Uncommon</b> (0.1% to 1%): Allergic skin reactions, erythema, itching</p>
<p><b>Very rare</b> (less than 0.01%): Urticaria</p>
<p><b>Frequency not reported</b>: Pruritus<sup>[Ref]</sup></p><p>Sweating occurred in patients with withdrawal symptoms.<sup>[Ref]</sup></p><h3>Ocular</h3><p>Double vision occurred at the start of treatment, but usually disappeared with continued use.<sup>[Ref]</sup></p><p>ORAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Blurred vision, diplopia</p>
<p><b>Frequency not reported</b>: Nystagmus, reversible visual disorders, visual disturbances</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Blurred vision, conjunctivitis, diplopia, nystagmus</p>
<p><b>Frequency not reported</b>: Reversible visual disorders, visual disturbances</p>
<p></p>
<p>RECTAL:</p>
<p><b>Common</b> (1% to 10%): Double vision/diplopia</p>
<p><b>Rare</b> (0.01% to 0.1%): Other visual disturbances</p>
<p><b>Frequency not reported</b>: Blurred vision, mydriasis, nystagmus, reversible visual disorders<sup>[Ref]</sup></p><h3>Hematologic</h3><p>ORAL:</p>
<p><b>Rare</b> (0.01% to 0.1%): Blood dyscrasias</p>
<p><b>Very rare</b> (less than 0.01%): Leukopenia, neutropenia</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Agranulocytosis, anemia, blood dyscrasias, leukopenia, neutropenia, thrombocytopenia</p>
<p></p>
<p>RECTAL:</p>
<p><b>Rare</b> (0.01% to 0.1%): Blood dyscrasias, thrombocytopenia</p>
<p><b>Very rare</b> (less than 0.01%): Leukopenia</p>
<p><b>Frequency not reported</b>: Anemia, neutropenia, lymphadenopathy<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>ORAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Incontinence, urinary retention</p>
<p><b>Rare</b> (0.01% to 0.1%): Impotence</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Difficulty in micturition</p>
<p><b>Rare</b> (0.01% to 0.1%): Impotence, incontinence, urinary retention</p>
<p><b>Frequency not reported</b>: Galactorrhea</p>
<p></p>
<p>RECTAL:</p>
<p><b>Rare</b> (0.01% to 0.1%): Impotence, incontinence, menstrual disturbances, urinary retention</p>
<p><b>Frequency not reported</b>: Urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p>ORAL:</p>
<p><b>Rare</b> (0.01% to 0.1%): Changes of hepatic parameters, elevation of ALT or AST, jaundice</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Hepatic dysfunction, jaundice</p>
<p><b>Rare</b> (0.01% to 0.1%): Changes of hepatic parameters, elevation of ALT or AST</p>
<p><b>Frequency not reported</b>: Cholestasis</p>
<p></p>
<p>RECTAL:</p>
<p><b>Rare</b> (0.01% to 0.1%): Changes of hepatic parameters, cholestatic jaundice, elevation of ALT or AST, hepatocellular jaundice, jaundice<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>ORAL:</p>
<p><b>Rare</b> (0.01% to 0.1%): Anaphylaxis, hypersensitivity reactions</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Immediate hypersensitivity reactions</p>
<p><b>Rare</b> (0.01% to 0.1%): Anaphylaxis</p>
<p></p>
<p>RECTAL:</p>
<p><b>Very rare</b> (less than 0.01%): Anaphylaxis, angioedema<sup>[Ref]</sup></p><h3>Renal</h3><p>PARENTERAL:</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased serum creatinine<sup>[Ref]</sup></p><h3>Endocrine</h3><p>ORAL:</p>
<p><b>Rare</b> (0.01% to 0.1%): Gynecomastia</p>
<p></p>
<p>PARENTERAL:</p>
<p><b>Rare</b> (0.01% to 0.1%): Gynecomastia</p>
<p><b>Frequency not reported</b>: Increased plasma testosterone levels, increased prolactin levels</p>
<p></p>
<p>RECTAL:</p>
<p><b>Rare</b> (0.01% to 0.1%): Gynecomastia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Valium (diazepam)." Roche Laboratories, Nutley, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Diastat (diazepam)." Athena Neurosciences Inc, South San Francisco, CA. </p><p id="ref_4">4. "Product Information. Dizac (diazepam)." Ohmeda Pharmaceutical Products Division, Liberty Corner, NJ. </p><p id="ref_5">5. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about diazepam</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>681 Reviews</li>
<li>Drug class: benzodiazepine anticonvulsants</li>
<li>FDA Alerts (2)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Diazepam injection</li>
<li>Diazepam nasal</li>
<li>Diazepam rectal</li>
<li>Diazepam &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li data-more-config-id="list-data-resources-consumer">... +3 more</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Valium, Diastat, Valtoco, Diazepam Intensol, ... +3 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +8 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Anxiety</li>
<li>Borderline Personality Disorder</li>
<li>Alcohol Withdrawal</li>
<li>Endoscopy or Radiology Premedication</li>
<li data-more-config-id="list-data-resources-conditions">... +12 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to diazepam: compounding powder, injectable solution, intravenous suspension, nasal spray, oral capsule extended release, oral concentrate, oral solution, oral tablet, rectal kit</i></p><h3>General</h3><p>ORAL: The most commonly reported side effects included ataxia, drowsiness, fatigue, and muscle weakness.</p><p></p><p>PARENTERAL: The most commonly reported side effects included fatigue, drowsiness, ataxia, injection-site venous thrombosis, and injection-site phlebitis.</p><p></p><p>RECTAL: The most commonly reported side effects included somnolence, headache, and diarrhea.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Drowsiness, headache, dizziness, ataxia, and reduced alertness occurred at the start of treatment, but usually disappeared with continued use.</p><p></p><p>Anterograde amnesia is a dose-related side effect that may occur at therapeutic doses.</p><p></p><p>Tremor, disrupted sensory perception, and epileptic attacks occurred in patients with withdrawal symptoms.</p><p></p><p>Drowsiness, sedation, unsteadiness, and ataxia are dose-related and may persist into the following day, even with single doses.</p><p></p><p>Prolonged use of treatment in elderly patients may result in dementia.<sup>[Ref]</sup></p><p>ORAL:</p><p><b>Common</b> (1% to 10%): Ataxia, disrupted sensory perception, drowsiness, epileptic attacks, impaired motor ability, tremor</p><p><b>Uncommon</b> (0.1% to 1%): Amnesia/anterograde amnesia, balance disorders, concentration difficulties, dizziness, dysarthria, headache, slurred speech, vertigo</p><p><b>Rare</b> (0.01% to 0.1%): Decreased alertness, memory loss, syncope, unconsciousness</p><p><b>Frequency not reported</b>: Abnormal taste, amnestic effects, hangover effect, hypersensitivity to physical/visual/auditory stimuli, oversedation, perceptual disturbances</p><p></p><p>PARENTERAL:</p><p><b>Common</b> (1% to 10%): Ataxia, disrupted sensory perception, dizziness, drowsiness, epileptic attacks, impaired motor ability, tremor</p><p><b>Uncommon</b> (0.1% to 1%): Amnesia/anterograde amnesia, balance disorders, concentration difficulties, headache, increased seizure incidence/severity, lightheadedness, minor electroencephalogram (EEG) changes, slurred speech, vertigo</p><p><b>Rare</b> (0.01% to 0.1%): Convulsions, decreased alertness, dysarthria, extrapyramidal effects, memory loss, syncope, unconsciousness</p><p><b>Frequency not reported</b>: Abnormal taste, amnestic effects, hangover effect, hypersensitivity to physical/visual/auditory stimuli, oversedation</p><p></p><p>RECTAL:</p><p><b>Very common</b> (10% or more): Somnolence (up to 23%)</p><p><b>Common</b> (1% to 10%): Ataxia, anterograde amnesia, convulsion, disrupted sensory perception, dizziness, drowsiness, dysarthria, epileptic attacks, hangover effect, headache, impaired motor ability, incoordination, reduced alertness, sedation, slurred speech, speech disorder, tremor, vertigo</p><p><b>Uncommon</b> (0.1% to 1%): Balance disorders, concentration difficulties</p><p><b>Rare</b> (0.01% to 0.1%): Dystonic effects, lightheadedness, memory loss, syncope, unconsciousness</p><p><b>Frequency not reported</b>: Grand mal convulsion, hyperkinesia, lethargy, minor changes in EEG patterns, nystagmus<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>ORAL:</p><p><b>Common</b> (1% to 10%): Aggression/aggressiveness, anxiety, confusion, delirium, irritability, panic, paranoid psychosis, withdrawal symptoms</p><p><b>Uncommon</b> (0.1% to 1%): Depression, changed/increased/reduced libido</p><p><b>Rare</b> (0.01% to 0.1%): Agitation, delusion, emotional poverty, excitation, hallucinations, inappropriate behavior, insomnia, nightmares, other adverse behavioral effects, psychiatric reactions, psychoses, rages, restlessness</p><p><b>Frequency not reported</b>: Acute hyperexcittion/acute hyperexcited states, broken sleep with vivid dreams, confusional psychosis, delirium tremens, increased REM sleep, numbed emotions, physical dependence, sleep disturbances, stimulation, unmasked depression</p><p></p><p>PARENTERAL:</p><p><b>Common</b> (1% to 10%): Aggression/aggressiveness, anxiety, confusion, delirium, dependence, irritability, panic, paranoid psychosis, withdrawal symptoms</p><p><b>Uncommon</b> (0.1% to 1%): Acute hyperexcittion/acute hyperexcited states, auditory/visual hallucinations, numbed emotion, sleep disturbances, stimulation, suicidal ideation</p><p><b>Rare</b> (0.01% to 0.1%): Agitation, delusion, depression/mental depression, emotional poverty, excitation, hallucinations, inappropriate behavior, increased/changed/reduced libido, insomnia, nightmares, other adverse behavioral effects, psychiatric reactions, psychoses, rages, restlessness</p><p><b>Frequency not reported</b>: Broken sleep with vivid dreams, confusional psychoses, delirium tremens, disinhibition, dysphoria, euphoria, habituation, hypoactivity, increased REM sleep, inhibition of female orgasm, unmasked depression</p><p></p><p>RECTAL:</p><p><b>Common</b> (1% to 10%): Aggression/aggressiveness, agitation, anxiety, confusion, delirium, emotional lability, euphoria, irritability, nervousness, numbed emotions, panic, paranoid psychosis, thinking abnormal, uneasiness, unmasked depression, withdrawal symptoms</p><p><b>Rare</b> (0.01% to 0.1%): Delusion, emotional poverty, excitation, hallucination, inappropriate behavior, increased/reduced libido, insomnia, libido fluctuations, nightmares, other adverse behavioral effects, psychiatric reactions, psychoses, rage, restlessness</p><p><b>Frequency not reported</b>: Abuse, acute hyperexcited states, changes in libido, depression, drug dependence, dysphoria, instability, sleep disturbances, stimulation, uncovering of depression with suicidal tendencies<sup>[Ref]</sup></p><p>Confusion and numbed emotions occurred at the start of treatment, but usually disappeared with continued use.  Confusion has occurred in elderly patients who received high doses.</p><p></p><p>Inappropriate behavior may occur with anterograde amnesia.</p><p></p><p>Psychic and physical dependence occurred with chronic use at therapeutic doses; withdrawal symptoms may occur in patients with dependence when treatment is discontinued.</p><p></p><p>Anxiety, panic, irritability, aggressiveness/aggression, paranoid psychosis, and delirium occurred in patients with withdrawal symptoms.</p><p></p><p>Restlessness, agitation, irritability, aggressiveness/aggression, rage, delusions, nightmares, psychoses, hallucinations, and inappropriate behavior occurred in patients with paradoxical reactions, especially in elderly and pediatric patients.</p><p></p><p>Increased REM sleep and broken sleep with vivid dreams may persist for weeks after treatment is discontinued.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Increased bronchial secretions were reported, especially in pediatric patients.</p><p></p><p>Respiratory depression and apnea occurred, especially with high doses.</p><p></p><p>Coughing, respiratory depression, dyspnea, hyperventilation, laryngospasm, and throat/chest pain have been reported in patients undergoing peroral endoscopic procedures.<sup>[Ref]</sup></p><p>ORAL:</p><p><b>Uncommon</b> (0.1% to 1%): Respiratory depression</p><p><b>Rare</b> (0.01% to 0.1%): Increased bronchial secretion, respiratory arrest</p><p><b>Frequency not reported</b>: Apnea</p><p></p><p>PARENTERAL:</p><p><b>Uncommon</b> (0.1% to 1%): Coughing, dyspnea, hyperventilation, laryngospasm, respiratory depression, throat pain</p><p><b>Rare</b> (0.01% to 0.1%): Increased bronchial secretion, respiratory arrest</p><p><b>Frequency not reported</b>: Apnea, hiccups</p><p></p><p>RECTAL:</p><p><b>Common</b> (1% to 10%): Asthma, hiccup, rhinitis</p><p><b>Uncommon</b> (0.1% to 1%): Respiratory depression</p><p><b>Rare</b> (0.01% to 0.1%): Apnea, increased bronchial secretion, laryngeal spasm, respiratory arrest</p><p><b>Frequency not reported</b>: Cough increased, hypoventilation<sup>[Ref]</sup></p><h3>Other</h3><p>ORAL:</p><p><b>Common</b> (1% to 10%): Fatigue, general malaise</p><p><b>Rare</b> (0.01% to 0.1%): Paradoxical reactions</p><p><b>Frequency not reported</b>: Accidents, falls, rebound effect, tinnitus</p><p></p><p>PARENTERAL:</p><p><b>Common</b> (1% to 10%): Fatigue, general malaise</p><p><b>Uncommon</b> (0.1% to 1%): Body pain, hyperpyrexia, hypothermia</p><p><b>Rare</b> (0.01% to 0.1%): Paradoxical reactions</p><p><b>Frequency not reported</b>: Pain</p><p></p><p>RECTAL:</p><p><b>Common</b> (1% to 10%): Falls, fatigue, general malaise, pain, paradoxical reactions</p><p><b>Frequency not reported</b>: Asthenia, lack of effect, rebound effect<sup>[Ref]</sup></p><p>Fatigue occurred at the start of treatment, but usually disappeared with continued use.</p><p></p><p>Elderly patients have an increased risk of falling.</p><p></p><p>Patients with physical/psychic dependence may experience rebound effects during discontinuation.</p><p></p><p>General malaise occurred in patients with withdrawal symptoms.</p><p></p><p>Pain occurred with injection formulations.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Palpitations occurred in patients with withdrawal symptoms.</p><p></p><p>Thrombophlebitis and venous thrombosis have occurred with injection formulations.</p><p></p><p>Ischemia occurred with inadvertent intra-arterial administration.<sup>[Ref]</sup></p><p>ORAL:</p><p><b>Common</b> (1% to 10%): Hypotension, palpitations</p><p><b>Rare</b> (0.01% to 0.1%): Bradycardia, heart failure (including cardiac arrest)</p><p><b>Frequency not reported</b>: Cardiovascular depression, chest pain, mild systolic hypertension, orthostatic hypotension, tachycardia</p><p></p><p>PARENTERAL:</p><p><b>Common</b> (1% to 10%): Palpitations</p><p><b>Uncommon</b> (0.1% to 1%): Bradycardia, cardiac arrest, chest pain, hypotension, other arrhythmias, tachycardia, ventricular premature contractions</p><p><b>Frequency not reported</b>: Mild systolic hypertension, orthostatic hypotension</p><p></p><p>RECTAL:</p><p><b>Common</b> (1% to 10%): Hypotension, palpitations, vasodilation</p><p><b>Rare</b> (0.01% to 0.1%): Bradycardia, chest pain, heart failure (including cardiac arrest)</p><p><b>Frequency not reported</b>: Cardiovascular collapse<sup>[Ref]</sup></p><h3>Local</h3><p>PARENTERAL:</p><p><b>Common</b> (1% to 10%): Local irritation, pain, phlebitis, swelling, venous thrombosis</p><p><b>Uncommon</b> (0.1% to 1%): Erythema, local pain, tenderness, vascular changes</p><p><b>Frequency not reported</b>: Ischemia, tissue necrosis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Muscle weakness occurred at the start of treatment, but usually disappeared with continued use.</p><p></p><p>Elderly patients and/or those taking sedatives/alcohol concomitantly have an increased risk of fractures associated with falls.</p><p></p><p>Muscle spasms occurred in patients with withdrawal symptoms.</p><p></p><p>Tissue necrosis occurred with inadvertent intra-arterial administration.<sup>[Ref]</sup></p><p>ORAL:</p><p><b>Common</b> (1% to 10%): Muscle spasms, muscle weakness</p><p><b>Uncommon</b> (0.1% to 1%): Myasthenia</p><p><b>Frequency not reported</b>: Muscle twitching</p><p><b>Postmarketing reports</b>: Fractures</p><p></p><p>PARENTERAL:</p><p><b>Common</b> (1% to 10%): Muscle spasms/increased muscle spasticity, muscle weakness</p><p><b>Uncommon</b> (0.1% to 1%): Increased phosphokinase activity, joint pain, muscle cramps, myasthenia</p><p><b>Frequency not reported</b>: Muscle aches, muscle twitching</p><p><b>Postmarketing reports</b>: Fractures</p><p></p><p>RECTAL:</p><p><b>Common</b> (1% to 10%): Muscle spasms, muscle weakness</p><p><b>Uncommon</b> (0.1% to 1%): Myasthenia</p><p><b>Frequency not reported</b>: Increased muscle spasticity, muscle cramps<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Increased salivation has been reported, especially in pediatric patients.</p><p></p><p>Gastrointestinal disorders occurred in patients with withdrawal symptoms.<sup>[Ref]</sup></p><p>ORAL:</p><p><b>Common</b> (1% to 10%): Gastrointestinal disorders</p><p><b>Uncommon</b> (0.1% to 1%): Constipation, diarrhea, dry mouth, hypersalivation, increased salivary secretion, nausea, vomiting</p><p><b>Frequency not reported</b>: Abdominal cramps</p><p></p><p>PARENTERAL:</p><p><b>Common</b> (1% to 10%): Gastrointestinal disorders</p><p><b>Uncommon</b> (0.1% to 1%): Constipation, decreased gag reflex, diarrhea, hypersalivation, increased salivary secretion, nausea, vomiting</p><p><b>Rare</b> (0.01% to 0.1%): Dry mouth</p><p><b>Frequency not reported</b>: Abdominal cramps, changes in salivation</p><p></p><p>RECTAL:</p><p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, gastrointestinal disorders</p><p><b>Uncommon</b> (0.1% to 1%): Changes in salivation, constipation, increased salivary secretion, nausea, vomiting</p><p><b>Rare</b> (0.01% to 0.1%): Dry mouth, epigastric pain, obstipation</p><p><b>Frequency not reported</b>: Abdominal cramps<sup>[Ref]</sup></p><h3>Metabolic</h3><p>ORAL:</p><p><b>Common</b> (1% to 10%): Loss of appetite</p><p><b>Uncommon</b> (0.1% to 1%): Increased appetite</p><p><b>Rare</b> (0.01% to 0.1%): Alkaline phosphatase elevations</p><p></p><p>PARENTERAL:</p><p><b>Common</b> (1% to 10%): Loss of appetite</p><p><b>Rare</b> (0.01% to 0.1%): Alkaline phosphatase elevations, increased appetite</p><p></p><p>RECTAL:</p><p><b>Common</b> (1% to 10%): Loss of appetite</p><p><b>Rare</b> (0.01% to 0.1%): Alkaline phosphatase elevations, increased appetite</p><p><b>Frequency not reported</b>: Anorexia<sup>[Ref]</sup></p><p>Appetite loss occurred in patients with withdrawal symptoms.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>ORAL:</p><p><b>Common</b> (1% to 10%): Sweating</p><p><b>Uncommon</b> (0.1% to 1%): Allergic skin reactions, erythema, itching, rash/skin rash</p><p><b>Frequency not reported</b>: Perspiration</p><p></p><p>PARENTERAL:</p><p><b>Uncommon</b> (0.1% to 1%): Allergic skin reactions, erythema, itching, photosensitivity, pruritus, rash/skin rash, urticaria</p><p><b>Frequency not reported</b>: Perspiration, Steven-Johnson syndrome, sweating</p><p></p><p>RECTAL:</p><p><b>Common</b> (1% to 10%): Rash, sweating</p><p><b>Uncommon</b> (0.1% to 1%): Allergic skin reactions, erythema, itching</p><p><b>Very rare</b> (less than 0.01%): Urticaria</p><p><b>Frequency not reported</b>: Pruritus<sup>[Ref]</sup></p><p>Sweating occurred in patients with withdrawal symptoms.<sup>[Ref]</sup></p><h3>Ocular</h3><p>Double vision occurred at the start of treatment, but usually disappeared with continued use.<sup>[Ref]</sup></p><p>ORAL:</p><p><b>Uncommon</b> (0.1% to 1%): Blurred vision, diplopia</p><p><b>Frequency not reported</b>: Nystagmus, reversible visual disorders, visual disturbances</p><p></p><p>PARENTERAL:</p><p><b>Uncommon</b> (0.1% to 1%): Blurred vision, conjunctivitis, diplopia, nystagmus</p><p><b>Frequency not reported</b>: Reversible visual disorders, visual disturbances</p><p></p><p>RECTAL:</p><p><b>Common</b> (1% to 10%): Double vision/diplopia</p><p><b>Rare</b> (0.01% to 0.1%): Other visual disturbances</p><p><b>Frequency not reported</b>: Blurred vision, mydriasis, nystagmus, reversible visual disorders<sup>[Ref]</sup></p><h3>Hematologic</h3><p>ORAL:</p><p><b>Rare</b> (0.01% to 0.1%): Blood dyscrasias</p><p><b>Very rare</b> (less than 0.01%): Leukopenia, neutropenia</p><p></p><p>PARENTERAL:</p><p><b>Uncommon</b> (0.1% to 1%): Agranulocytosis, anemia, blood dyscrasias, leukopenia, neutropenia, thrombocytopenia</p><p></p><p>RECTAL:</p><p><b>Rare</b> (0.01% to 0.1%): Blood dyscrasias, thrombocytopenia</p><p><b>Very rare</b> (less than 0.01%): Leukopenia</p><p><b>Frequency not reported</b>: Anemia, neutropenia, lymphadenopathy<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>ORAL:</p><p><b>Uncommon</b> (0.1% to 1%): Incontinence, urinary retention</p><p><b>Rare</b> (0.01% to 0.1%): Impotence</p><p></p><p>PARENTERAL:</p><p><b>Uncommon</b> (0.1% to 1%): Difficulty in micturition</p><p><b>Rare</b> (0.01% to 0.1%): Impotence, incontinence, urinary retention</p><p><b>Frequency not reported</b>: Galactorrhea</p><p></p><p>RECTAL:</p><p><b>Rare</b> (0.01% to 0.1%): Impotence, incontinence, menstrual disturbances, urinary retention</p><p><b>Frequency not reported</b>: Urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p>ORAL:</p><p><b>Rare</b> (0.01% to 0.1%): Changes of hepatic parameters, elevation of ALT or AST, jaundice</p><p></p><p>PARENTERAL:</p><p><b>Uncommon</b> (0.1% to 1%): Hepatic dysfunction, jaundice</p><p><b>Rare</b> (0.01% to 0.1%): Changes of hepatic parameters, elevation of ALT or AST</p><p><b>Frequency not reported</b>: Cholestasis</p><p></p><p>RECTAL:</p><p><b>Rare</b> (0.01% to 0.1%): Changes of hepatic parameters, cholestatic jaundice, elevation of ALT or AST, hepatocellular jaundice, jaundice<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>ORAL:</p><p><b>Rare</b> (0.01% to 0.1%): Anaphylaxis, hypersensitivity reactions</p><p></p><p>PARENTERAL:</p><p><b>Uncommon</b> (0.1% to 1%): Immediate hypersensitivity reactions</p><p><b>Rare</b> (0.01% to 0.1%): Anaphylaxis</p><p></p><p>RECTAL:</p><p><b>Very rare</b> (less than 0.01%): Anaphylaxis, angioedema<sup>[Ref]</sup></p><h3>Renal</h3><p>PARENTERAL:</p><p><b>Uncommon</b> (0.1% to 1%): Increased serum creatinine<sup>[Ref]</sup></p><h3>Endocrine</h3><p>ORAL:</p><p><b>Rare</b> (0.01% to 0.1%): Gynecomastia</p><p></p><p>PARENTERAL:</p><p><b>Rare</b> (0.01% to 0.1%): Gynecomastia</p><p><b>Frequency not reported</b>: Increased plasma testosterone levels, increased prolactin levels</p><p></p><p>RECTAL:</p><p><b>Rare</b> (0.01% to 0.1%): Gynecomastia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Valium (diazepam)." Roche Laboratories, Nutley, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Diastat (diazepam)." Athena Neurosciences Inc, South San Francisco, CA. </p><p id="ref_4">4. "Product Information. Dizac (diazepam)." Ohmeda Pharmaceutical Products Division, Liberty Corner, NJ. </p><p id="ref_5">5. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about diazepam</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>681 Reviews</li>
<li>Drug class: benzodiazepine anticonvulsants</li>
<li>FDA Alerts (2)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Diazepam injection</li>
<li>Diazepam nasal</li>
<li>Diazepam rectal</li>
<li>Diazepam &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li data-more-config-id="list-data-resources-consumer">... +3 more</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +8 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Anxiety</li>
<li>Borderline Personality Disorder</li>
<li>Alcohol Withdrawal</li>
<li>Endoscopy or Radiology Premedication</li>
<li data-more-config-id="list-data-resources-conditions">... +12 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>